Triphasil-21 side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Triphasil-21 (ethinyl estradiol; levonorgestrel). Common side effects include menometrorrhagia among females and abdominal distension among males.
The phase IV clinical study is created by eHealthMe based on 531 reports from the FDA, and is updated regularly.
What is Triphasil-21?
Triphasil-21 has active ingredients of ethinyl estradiol; levonorgestrel. eHealthMe is studying from 534 Triphasil-21 users. Check the latest studies of Triphasil-21.
531 people who take Triphasil-21 and have side effects are studied.
What are the common side effects of Triphasil-21, by gender? *
What are the common side effects of Triphasil-21, by age (0-1 to 60+)? *
What are the common side effects of Triphasil-21, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Triphasil-21?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on ethinyl estradiol; levonorgestrel (the active ingredients of Triphasil-21) and Triphasil-21 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Triphasil-21:
- Triphasil-21 (534 reports)
All Triphasil-21 side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Skin Plaque and drugs of ingredients of alefacept - 3 seconds ago
- Pulmicort and Drug Ineffective for Girls aged 10-19 - 6 seconds ago
- Pulmicort and Not Effective for Girls aged 10-19 - 7 seconds ago
- Could Iodine cause Taste - Impaired? - 9 seconds ago
- Could Adagen cause Death? - 12 seconds ago
- Nabumetone and Broken Bone for Women aged 50-59 - 13 seconds ago
- Nabumetone and Stress Fracture for Women aged 50-59 - 13 seconds ago
- Nabumetone and Fracture for Women aged 50-59 - 13 seconds ago
- Nabumetone and Bone - Broken for Women aged 50-59 - 14 seconds ago
- Clarithromycin and High Blood Cholesterol for Women aged 60+ - 15 seconds ago